CIFOBAN

This brand name is authorized in Ireland, Romania

Active ingredients

The drug CIFOBAN contains one active pharmaceutical ingredient (API):

1 Trisodium citrate dihydrate UNII B22547B95K - TRISODIUM CITRATE DIHYDRATE

Sodium citrate has no relevant pharmacodynamic activity other than that caused by its alkalinity (e.g. its gastric acid neutralising capacity). Sodium citrate is a non-particulate antacid for use by mouth to prior to general anaesthesia for caesarean section. Read about Sodium citrate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CIFOBAN Solution for infusion	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B05ZB	Hemofiltrates	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05Z Hemodialytics and hemofiltrates
Discover more medicines within B05ZB

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68772001, W68772002